text: Multiple biomarkers such as C-reactive protein, von Willebrand factor and NT-pro-BNP are used to predict all cause mortality in patients with CAV. Elevated levels of each of these biomarkers signify increased risk of developing CAV. Further research is warranted to help identify the role of biomarkers in diagnosing and predicting CAV.
option_0: Cardiac allograft vasculopathy laboratory findings
option_1: Sarcoidosis laboratory findings
option_2: Cardiac allograft vasculopathy intravascular ultrasound
option_3: Cardiac allograft vasculopathy screening
option_4: Cardiac allograft vasculopathy optical coherence tomography
option_5: Graft-versus-host disease laboratory findings
option_6: Heart transplantation classification
option_7: Cardiac allograft vasculopathy coronary angiography